Cargando…

Ceftriaxone as an Alternative Therapy for the Treatment of Methicillin-Susceptible Staphylococcus aureus Bacteremia after Initial Clearance of Bloodstream Infection

INTRODUCTION: Staphylococcus spp. represent the leading cause of hospital-acquired infections and second-most frequent pathogen in bloodstream infections. Methicillin-susceptible S. aureus (MSSA) comprise approximately half of all S. aureus isolates. Standard-of-care therapies (SOCTs) display high t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Barber, Katie E., Cramer, Rachel A., Bell, Allison M., Wagner, Jamie L., Stover, Kayla R
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2021
Materias:	Case Series
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8093069/ https://www.ncbi.nlm.nih.gov/pubmed/33986964 http://dx.doi.org/10.1155/2021/8884685

Ejemplares similares

Ceftriaxone for the Treatment of Methicillin-susceptible Staphylococcus aureus Bacteremia: A Case Series
por: Lowe, Rachel Amanda, et al.
Publicado: (2017)

266. Ceftriaxone Versus Cefazolin for the Treatment of Methicillin-Susceptible Staphylococcus aureus Bacteremia
por: Mohamed, Adham, et al.
Publicado: (2020)

Dalbavancin Use for the Treatment of Methicillin-resistant Staphylococcus aureus Pneumonia
por: Barber, Katie E., et al.
Publicado: (2017)

1512. Treatment of Staphylococcus aureus Bacteremia in a Pediatric Population: A Retrospective Cohort Analysis
por: Gunter, Sarah G, et al.
Publicado: (2019)

Intravenous versus Oral Step-Down for the Treatment of Staphylococcus aureus Bacteremia in a Pediatric Population
por: Gunter, Sarah Grace, et al.
Publicado: (2022)

217. Eosinophil count recovery as a predictor of bloodstream clearance in Staphylococcus aureus bacteremia
por: McHugh, Jack W, et al.
Publicado: (2023)

Impact of Obesity on Ceftriaxone Efficacy †
por: Barber, Katie E., et al.
Publicado: (2020)

738. Outcomes of Ceftriaxone Versus Antistaphylococcal Penicillins or Cefazolin for Definitive Therapy of Methicillin-susceptible Staphylococcus aureus Bacteremia
por: Khodadadi, Ryan B, et al.
Publicado: (2022)

Staphylococcus aureus Prostatic Abscess in the Setting of Prolonged S. aureus Bacteremia
por: Eichenberger, Emily M., et al.
Publicado: (2020)

Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia
por: Choo, Eun Ju, et al.
Publicado: (2016)

Successful Clearance of Persistent Methicillin-Resistant Staphylococcus aureus Bacteremia with Daptomycin, Linezolid, and Meropenem Salvage Therapy
por: Shaddix, Grant, et al.
Publicado: (2019)

1381. Impact of Total Body Weight on Efficacy of Ceftriaxone in Obese Patients
por: Wagner, Jamie L, et al.
Publicado: (2018)

Outcomes of Outpatient Parenteral Antimicrobial Therapy With Ceftriaxone for Methicillin-Susceptible Staphylococcus aureus Bloodstream Infections—A Single-Center Observational Study
por: Hamad, Yasir, et al.
Publicado: (2020)

Methicillin Resistant Staphylococcus aureus Prostatic Abscess with Bacteremia
por: Lachant, Daniel J., et al.
Publicado: (2013)

Staphylococcus aureus Bacteremia in Children: The Effect of Methicillin Resistance
por: Hamdy, Rana F, et al.
Publicado: (2017)

Cataract surgery during active methicillin-resistant Staphylococcus aureus infection
por: Mansour, Ahmad M, et al.
Publicado: (2014)

730 A Retrospective Comparison of Self – Administered Ceftriaxone vs Cefazolin for Methicillin-Susceptible Staphylococcus Aureus Bacteremia in an Outpatient Antibiotic Therapy Setting.
por: Diamante, Oliver, et al.
Publicado: (2014)

1057. Treatment Efficacy of Ceftriaxone vs. Cefazolin for Methicillin-Susceptible Staphylococcus aureus Infections
por: Bhavan, Kavita, et al.
Publicado: (2018)

Methicillin‐resistant Staphylococcus aureus in health‐care workers with cystic fibrosis in Sydney
por: Song, Yang, et al.
Publicado: (2018)

Effectiveness and Safety of Ceftriaxone Compared to Standard of Care for Treatment of Bloodstream Infections Due to Methicillin-Susceptible Staphylococcus aureus: A Systematic Review and Meta-Analysis
por: Alsowaida, Yazed Saleh, et al.
Publicado: (2022)

366. Impact of Obesity in Patients With Candida Bloodstream Infections
por: Barber, Katie E, et al.
Publicado: (2018)

460. Ceftriaxone vs. Standard of Care for Definitive Treatment of Methicillin-Susceptible Staphylococcus aureus Infections
por: Snawerdt, Jessica, et al.
Publicado: (2019)

Usefulness of previous methicillin-resistant Staphylococcus aureus screening results in guiding empirical therapy for S aureus bacteremia
por: Bai, Anthony D, et al.
Publicado: (2015)

High Vancomycin MIC and Complicated Methicillin-Susceptible Staphylococcus aureus Bacteremia
por: Aguado, Jose Maria, et al.
Publicado: (2011)

850. External Validation of the Methicillin-Resistant Staphylococcus aureus Bacteremia Score
por: Boyle, Ellen, et al.
Publicado: (2020)

Association of methicillin resistance with mortality of hospital-acquired Staphylococcus aureus bacteremia
por: Aratani, Tomonori, et al.
Publicado: (2021)

Endogenous Endopthalmitis in Disseminated Methicillin-Sensitive Staphylococcus aureus (MSSA) Bacteremia
por: Saidi, Noor Amalina, et al.
Publicado: (2023)

Persistent Methicillin-Resistant Staphylococcus aureus Bacteremia: Host, Pathogen, and Treatment
por: Parsons, Joshua B., et al.
Publicado: (2023)

Is a single set of negative blood cultures sufficient to ensure clearance of bloodstream infection in patients with Staphylococcus aureus bacteremia? The skip phenomenon
por: Fiala, Justin, et al.
Publicado: (2019)

Teicoplanin versus β-lactam for febrile patients with Staphylococcus-like bacteremia: focus on methicillin-susceptible Staphylococcus aureus bacteremia
por: Tsai, Ching-Yen, et al.
Publicado: (2021)

187. Vancomycin Plus Ceftaroline Salvage Therapy for Persistent Methicillin-Resistant Staphylococcus aureus Bacteremia
por: Kufel, Wesley D, et al.
Publicado: (2021)

Fluoroquinolone Versus Nonfluoroquinolone Treatment of Bloodstream Infections Caused by Chromosomally Mediated AmpC-Producing Enterobacteriaceae
por: Gunter, Sarah Grace, et al.
Publicado: (2020)

850. Outcomes of Patients Discharged on Parenteral Ceftriaxone Compared with Oxacillin or Cefazolin in Methicillin-susceptible Staphylococcal aureus (MSSA) Bloodstream Infections
por: Erik Connor, Lee, et al.
Publicado: (2019)

Emergence of Livestock-Associated Methicillin-Resistant Staphylococcus aureus Bloodstream Infections in Denmark
por: Larsen, Jesper, et al.
Publicado: (2017)

Genomic epidemiology of methicillin-resistant and -susceptible Staphylococcus aureus from bloodstream infections
por: Smith, Joshua T., et al.
Publicado: (2021)

Increases in methicillin-sensitive Staphylococcus aureus bloodstream infection incidence, 2016–2019
por: Jackson, Kelly, et al.
Publicado: (2022)

Bacteremia and endocarditis due to methicillin-resistant Staphylococcus aureus: the potential role of daptomycin
por: Bamberger, David M
Publicado: (2007)

Empyema Necessitans in the Setting of Methicillin-Susceptible Staphylococcus aureus Causing Pneumonia and Bacteremia
por: Bandaru, Sindhura, et al.
Publicado: (2018)

Microbiological and genotypic factors affecting mortality in methicillin-resistant Staphylococcus aureus bacteremia
por: Joo, Eun-Jeong
Publicado: (2019)

Reevaluation of the impact of methicillin-resistance on outcomes in patients with Staphylococcus aureus bacteremia and endocarditis
por: Joo, Eun-Jeong, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_tt8ahqpraio739fstis90nil0i